Tuesday, October 29, 2013
12:00 PM ET
Presented by Ellen T. Matloff, MS, CGC, this webinar will highlight:
• How to determine which patients require genetic counseling
• How to help prepare your patients for the genetic counseling process
• Testing options that are now available
• How you can utilize this data in managing your patients and their family members
Angelina Jolie’s recent public disclosure regarding her BRCA1 mutation and subsequent double mastectomy, and the recent Supreme Court decision banning gene patents have forever changed the landscape of cancer genetic counseling and testing.
During this webinar, you will learn: how to determine which of your patients require genetic counseling; how to help prepare your patients for the genetic counseling process; what testing options are now available; and how you can utilize this data in managing your patients as well as their family members.
Ellen T. Matloff, MS, CGC, is a research scientist in genetics, and director of the Yale School of Medicine Cancer Center Genetic Counseling Program.
Board-certified in genetic counseling, Ms. Matloff specializes in hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2), hereditary colon cancer syndromes (HNPCC, FAP), and rare cancer syndromes.
Her research interests include patient and provider issues in genetic counseling, adverse events in genetics testing, and the impact of patents on clinical practice.
Ms. Matloff was a lead plaintiff in the 2013 Supreme Court case against gene patenting.
Webinar Archive Registration
To register for this webinar, please complete the form below. Take care to provide all required information (indicated in red
). Press Register
to complete your registration. If you have already registered for our site or for one of our webinars, you may login
to register without re-entering your information.